AR023099A1 - Constructos de adn que codifican saratina y sus usos. - Google Patents

Constructos de adn que codifican saratina y sus usos.

Info

Publication number
AR023099A1
AR023099A1 ARP000101192A ARP000101192A AR023099A1 AR 023099 A1 AR023099 A1 AR 023099A1 AR P000101192 A ARP000101192 A AR P000101192A AR P000101192 A ARP000101192 A AR P000101192A AR 023099 A1 AR023099 A1 AR 023099A1
Authority
AR
Argentina
Prior art keywords
collagen
natural
protein
cells
saratina
Prior art date
Application number
ARP000101192A
Other languages
English (en)
Inventor
Wolfgang Strittmatter
Detlef Guessow
Uwe Hofmann
Juergen Hemberger
Zisi Fotev
Bernhard Scheuble
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR023099A1 publication Critical patent/AR023099A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describe una proteína natural aislada de la saliva de la sanguijuela medicinal Hirudo medicinalis que se une fuertemente al colágeno, actuando de estamanera como un inhibidor de la adherencia natural de las plaquetas al colágeno. La proteína tieneun peso molecular de aproximadamente 12000, un puntoisoeléctrico ácido y contiene seis cisteínas. La proteína fue secuenciada y el gen fue clonado a partir de la biblioteca de ADNc de H. Medicinalis. También sedan a conocer procedimientos para producir tal polipéptido por medio de técnicas recombinantes. Tanto las proteínas naturales como las quiméricas soninhibidores potentes de la adherencia de plaquetas dependiente del colágeno y, por lo tanto, pueden ser utilizadas para el tratamiento terapéutico de diversascondiciones relacionadas con la enfermedad cardíaca y las enfermedades del sistema circulatorio. Además, la proteína también es apropiada para recubrirsuperficies naturales o artificiales de colágeno con el fin de volverlas no adhesivas para las células y de esta manera prevenir la activacion de células.
ARP000101192A 1999-03-18 2000-03-17 Constructos de adn que codifican saratina y sus usos. AR023099A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99105530 1999-03-18
EP99109503 1999-05-12

Publications (1)

Publication Number Publication Date
AR023099A1 true AR023099A1 (es) 2002-09-04

Family

ID=26152935

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101192A AR023099A1 (es) 1999-03-18 2000-03-17 Constructos de adn que codifican saratina y sus usos.

Country Status (27)

Country Link
US (3) US6774107B1 (es)
EP (1) EP1161530B1 (es)
JP (1) JP4805461B2 (es)
KR (1) KR100788219B1 (es)
CN (1) CN1185344C (es)
AR (1) AR023099A1 (es)
AT (1) ATE295883T1 (es)
AU (1) AU767172B2 (es)
BR (1) BR0009074A (es)
CA (1) CA2367457C (es)
CO (1) CO5241328A1 (es)
CZ (1) CZ301524B6 (es)
DE (1) DE60020220T2 (es)
DK (1) DK1161530T3 (es)
ES (1) ES2240067T3 (es)
HK (1) HK1045330B (es)
HU (1) HU228068B1 (es)
MX (1) MXPA01009363A (es)
MY (1) MY123371A (es)
NO (1) NO330769B1 (es)
PL (1) PL200384B1 (es)
PT (1) PT1161530E (es)
RU (1) RU2292351C2 (es)
SI (1) SI1161530T1 (es)
SK (1) SK287496B6 (es)
TR (1) TR200102729T2 (es)
WO (1) WO2000056885A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056885A1 (en) 1999-03-18 2000-09-28 Merck Patent Gmbh Protein for blocking platelet adhesion
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen
CA2453986A1 (en) * 2001-07-18 2003-01-30 Merck Patent Gesellschaft Mit Beschraenkter Haftung Glycoprotein vi fusion proteins
US7053051B2 (en) 2003-10-28 2006-05-30 Medtronic, Inc. Methods of preparing crosslinked materials and bioprosthetic devices
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
KR101340580B1 (ko) * 2004-10-12 2013-12-11 보드 오브 트러스티즈 오브 미시건 스테이트 유니버시티 플로로글루시놀의 생합성 및 이로부터1,3-디하이드록시벤젠의 합성
US8999370B2 (en) * 2005-05-26 2015-04-07 Thomas Jefferson University Method to treat and prevent posterior capsule opacification
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
US7691839B2 (en) 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
US20080015145A1 (en) * 2006-07-11 2008-01-17 Maria Gyongyossy-Issa Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
GB2462022B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
HUE035888T2 (en) 2008-10-15 2018-05-28 Ionis Pharmaceuticals Inc Modulation of Factor 11 Expression
WO2012003461A2 (en) 2010-07-02 2012-01-05 Draths Corporation Phloroglucinol synthases and methods of making and using the same
WO2012006244A1 (en) 2010-07-06 2012-01-12 Draths Corporation Method for producing phloroglucinol and dihydrophloroglucinol
WO2012006245A1 (en) 2010-07-06 2012-01-12 Draths Corporation Phloroglucinol reductase and methods of making and using the same
DK3333188T3 (da) 2010-08-19 2022-03-07 Zoetis Belgium S A Anti-NGF-antistoffer og deres anvendelse
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels
ES2894852T3 (es) 2012-06-06 2022-02-16 Zoetis Services Llc Anticuerpos anti-NGF caninizados y métodos de los mismos
CA2879443A1 (en) 2012-07-19 2014-01-23 Zoetis Llc Bovine influenza virus compositions
AU2013295770A1 (en) 2012-07-27 2015-01-29 Zoetis Services Llc Tick toxin compositions
CA3033759C (en) 2016-08-17 2022-06-14 Pharmaq As Sea lice vaccine
BR102017005783A2 (pt) * 2017-03-21 2018-10-02 Fund Butantan processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos
EP3765499A1 (en) 2018-03-12 2021-01-20 Zoetis Services LLC Anti-ngf antibodies and methods thereof
JP7449234B2 (ja) 2018-03-16 2024-03-13 ゾエティス・サービシーズ・エルエルシー 獣医学使用のためのインターロイキン３１モノクローナル抗体
KR102672548B1 (ko) 2018-03-16 2024-06-04 조에티스 서비시즈 엘엘씨 인터루킨-31에 대한 펩티드 백신
SG11202010012PA (en) 2018-05-09 2020-11-27 Ionis Pharmaceuticals Inc Compounds and methods for reducing fxi expression
MX2022002994A (es) 2019-09-11 2022-06-14 Zoetis Services Llc Vectores de herpesvirus de los pavos recombinante que expresan antígenos de patógenos aviares y usos de estos.
US20220119513A1 (en) 2020-06-08 2022-04-21 Zoetis Services Llc Anti-tgfb antibodies and therapeutic uses thereof
US20210386854A1 (en) 2020-06-15 2021-12-16 Zoetis Services Llc Cell Line for Production of Marek's Disease Virus Vaccine and Methods of Making and Using the Same
CA3198362A1 (en) 2020-10-07 2022-04-14 Zoetis Services Llc Anti-ngf antibodies and methods of use thereof
TW202221039A (zh) 2020-10-19 2022-06-01 美商碩騰服務公司 犬及貓抑瘤素Ｍ受體β之抗體及其用途
WO2023049917A1 (en) 2021-09-27 2023-03-30 Zoetis Services Llc ANTI- TGFβ1,2,3 ANTIBODIES AND THERAPEUTIC USES THEREOF

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705355A (en) * 1984-03-27 1998-01-06 Transgene, S.A. Hirudin, pharmaceutical compositions comprising it and their use
US4898734A (en) 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
IL86857A (en) * 1988-06-24 1994-04-12 Yissum Res Dev Co Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
US5182260A (en) * 1989-01-27 1993-01-26 Biogen, Inc. Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them
CA2052486A1 (en) * 1990-10-09 1992-04-10 Thomas M. Connolly Protein for inhibiting collagen-stimulated platelet aggregation
GB9022040D0 (en) * 1990-10-10 1990-11-21 Biopharm Ltd Platelet adhesion inhibitor
DE4136513A1 (de) * 1991-11-06 1993-05-13 Basf Ag Neues thrombininhibitorisches protein aus raubwanzen
JP3742429B2 (ja) * 1993-07-01 2006-02-01 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング コラーゲン刺激血小板凝集の阻害剤
EP1118325B2 (en) 1993-07-29 2010-01-06 The United States of America, represented by the Secretary, Department of Health and Human Services Use of Paclitaxel and its derivatives in the manufacture of a medicament for treating restenosis.
HU222398B1 (hu) * 1994-09-12 2003-06-28 Schering Aktiengesellschaft Eljárás pallidipin, egy módosított, kollagénindukált vérlemezke-aggregációt gátló vegyület előállítására
WO1996013585A1 (en) * 1994-10-28 1996-05-09 Clodica S.A. A novel family of protease inhibitors, and other biologic active substances
WO2000056885A1 (en) 1999-03-18 2000-09-28 Merck Patent Gmbh Protein for blocking platelet adhesion
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen

Also Published As

Publication number Publication date
NO20014506L (no) 2001-11-16
DK1161530T3 (da) 2005-08-08
DE60020220T2 (de) 2006-05-24
US6962801B2 (en) 2005-11-08
CA2367457C (en) 2010-09-21
CZ20013341A3 (cs) 2002-01-16
TR200102729T2 (tr) 2002-04-22
KR20020008131A (ko) 2002-01-29
US7090986B2 (en) 2006-08-15
PL350147A1 (en) 2002-11-04
HUP0200353A2 (hu) 2002-05-29
JP2002539788A (ja) 2002-11-26
US6774107B1 (en) 2004-08-10
PT1161530E (pt) 2005-09-30
HK1045330B (zh) 2005-09-09
WO2000056885A1 (en) 2000-09-28
US20060094079A1 (en) 2006-05-04
HUP0200353A3 (en) 2003-12-29
PL200384B1 (pl) 2008-12-31
MY123371A (en) 2006-05-31
RU2292351C2 (ru) 2007-01-27
AU767172B2 (en) 2003-11-06
HU228068B1 (en) 2012-09-28
CO5241328A1 (es) 2003-01-31
CN1185344C (zh) 2005-01-19
CZ301524B6 (cs) 2010-03-31
EP1161530A1 (en) 2001-12-12
NO20014506D0 (no) 2001-09-17
ATE295883T1 (de) 2005-06-15
EP1161530B1 (en) 2005-05-18
SK12902001A3 (sk) 2002-03-05
BR0009074A (pt) 2002-01-02
KR100788219B1 (ko) 2007-12-26
DE60020220D1 (de) 2005-06-23
CA2367457A1 (en) 2000-09-28
CN1344318A (zh) 2002-04-10
AU3166200A (en) 2000-10-09
ES2240067T3 (es) 2005-10-16
HK1045330A1 (en) 2002-11-22
SK287496B6 (sk) 2010-12-07
MXPA01009363A (es) 2002-06-04
US20050065084A1 (en) 2005-03-24
JP4805461B2 (ja) 2011-11-02
SI1161530T1 (en) 2005-10-31
NO330769B1 (no) 2011-07-11

Similar Documents

Publication Publication Date Title
AR023099A1 (es) Constructos de adn que codifican saratina y sus usos.
C. Schröder et al. Stimulation of protein (collagen) synthesis in sponge cells by a cardiac myotrophin‐related molecule from Suberites domuncula
BR0109494A (pt) Produção de fatores recombinantes de coagulação do sangue em linhas celulares humanas
ES2161246T3 (es) Factor transformante de crecimiento alfa h1.
ATE192500T1 (de) Rekombinante viren vektoren zur expression in muskelzellen
DE3684892D1 (de) Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens.
HUP9800075A2 (hu) Nukleinsav-konstrukciók proteázokkal aktíválható hatóanyagok expresszálására valamint előállításuk és alkalmazásuk
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
DK0861261T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Delta-gener og fremgangsmåder baseret derpå
ATE426024T1 (de) C-c chemokin rezeptor 3: ckr-3 oder eos-l2
DK0808367T3 (da) Vaskulære slimhindeaddressiner samt anvendelse deraf
DE68914316T2 (de) Polypeptide aus Vipergift und deren Genexpression.
HUP0002472A2 (hu) Izolált dendritikus sejtmembrán-fehérje gének
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
CA2648649A1 (en) Antagonists against interaction of pf4 and rantes
US5851983A (en) Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
ECSP003383A (es) Proteina para bloquear la adherencia plaquetaria
JPH0570364A (ja) 骨への破骨細胞付着を阻害する組成物及び方法
US5232912A (en) Anticoagulant peptides
ATE452970T1 (de) N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen
CN100432102C (zh) 血小板增进蛋白及其应用
JP2805384B2 (ja) 機能性ポリペプチド
SA98190913A (ar) طريقة حث وتكوين الخلايا المنشئة لمكونات الدم
JPH02138197A (ja) 内皮細胞から誘導された組換え血小板由来成長因子ａ−鎖
TH12889A (th) เคอร์คูลิน บี และคีเอ็นเอที่เป็นรหัสของสารดังกล่าว และขบวนการสำหรับการผลิตสารดังกล่าว

Legal Events

Date Code Title Description
FG Grant, registration